Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
Recap by typeshit. Post by Omer Raheem on X.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.
Zhavoronkov links recorded ARDD 2026 sessions, among them Lilly's Kevin Duffin speaking on tirzepatide and aging clocks.
Zhavoronkov quotes a speaker calling Mounjaro one of the best molecules humans have made, alongside Novo's semaglutide data at the aging conference.
Beauty companies are reportedly exploring products aimed at facial volume loss in people who have lost weight on GLP-1 drugs.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
Loading…